Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel

Inclusion Criteria:

• History of motion sickness
• Age 18-75

Exclusion Criteria:

• Nausea-inducing disorder other than motion sickness
• BMI>40
• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists